Article
Two faces of chondroitin sulfate proteoglycan in spinal cord repair: a role in microglia/macrophage activation.
PLoS medicine - 19 Aug 2008
Rolls Asya, Shechter Ravid, London Anat, Segev Yifat, Jacob-Hirsch Jasmin, Amariglio Ninette, Rechavi Gidon, Schwartz Michal
Abstract excerpt
BACKGROUND: Chondroitin sulfate proteoglycan (CSPG) is a major component of the glial scar. It is considered to be a major obstacle for central nervous system (CNS) recovery after injury, especially in light of its well-known activity in limiting axonal growth. Therefore, its degradation has become a key therapeutic goal in the field of CNS regeneration. Yet, the abundant de novo synthesis of CSPG in response to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
